Characterization of a survival pathway controlled by FGFR4 in alveolar Rhabdomyosarcoma

被引：0
|
作者：
Wachtel, Marco
Schafer, Beat
机构：
来源：
CANCER RESEARCH | 2010年 / 70卷
关键词：
D O I：
10.1158/1538-7445.AM10-3418
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
3418
引用
收藏
页数：3
相关论文
共 50 条
  • [41] FGFR4 Splice Variants in Adrenocortical Carcinomas
    Furlan, Karina
    Boyle, Theresa
    Saeed-Vafa, Daryoush
    LABORATORY INVESTIGATION, 2023, 103 (03) : S487 - S487
  • [42] The Role FGFR4 in Pancreatic Endocrine Tumors
    Serra, S.
    Ezzat, S.
    Chetty, R.
    Asa, S. L.
    MODERN PATHOLOGY, 2009, 22 : 120A - 120A
  • [43] Involvement of FGFR4 in Pulmonary Fibrosis Pathophysiology
    Ghanem, M.
    Justet, A.
    Jaillet, M.
    Hachem, M.
    Boghanim, T.
    Vadel, A.
    Mailleux, A.
    Crestani, B.
    AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2021, 203 (09)
  • [44] Survival With Persistent Metastatic Alveolar Rhabdomyosarcoma
    Louie, Ronald R.
    Harris, Michael
    Shields, Kathleen
    JOURNAL OF ONCOLOGY PRACTICE, 2017, 13 (05) : 341 - +
  • [45] Insight into ponatinib resistance mechanisms in rhabdomyosarcoma caused by the mutations in FGFR4 tyrosine kinase using molecular modeling strategies
    Wu, Chao
    Chen, Xiaolu
    Chen, Daoxing
    Xia, Qinqin
    Liu, Zhiguo
    Li, Fuchuan
    Yan, Yuxiang
    Cai, Yuepiao
    INTERNATIONAL JOURNAL OF BIOLOGICAL MACROMOLECULES, 2019, 135 : 294 - 302
  • [46] FGFR4 and CD276 dualtargeting CAR-T cells for treating rhabdomyosarcoma and other solid tumors
    Tian, Meijie
    Cheuk, Adam
    Milewski, David
    Wei, Jun S.
    Chou, Hsien-Chao
    Kim, Yong Yean
    Song, Young K.
    St Croix, Brad
    Ho, Mitchell
    Khan, Javed
    CANCER RESEARCH, 2022, 82 (12)
  • [47] Discovery & characterization of a next-generation FGFR4 inhibitor overcoming resistant mutations
    Ying, Haiyan
    Zhang, Nannan
    Deng, Haibing
    Yang, Fei
    Xin, Wenqun
    Shen, Bin
    Yu, Hongping
    Chen, Zhui
    Xu, Yao-chang
    CANCER RESEARCH, 2023, 83 (08)
  • [48] Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
    Kristen C Hart
    Scott C Robertson
    Martha Y Kanemitsu
    April N Meyer
    John A Tynan
    Daniel J Donoghue
    Oncogene, 2000, 19 : 3309 - 3320
  • [49] Multiplexed gene expression profiling identifies the FGFR4 pathway as a novel biomarker in intrahepatic cholangiocarcinoma
    Yoo, Changhoon
    Kang, Jihoon
    Kim, Deokhoon
    Kim, Kyu-Pyo
    Ryoo, Baek-Yeol
    Hong, Seung-Mo
    Hwang, Jung Jin
    Jeong, Seong-Yun
    Hwang, Shin
    Kim, Ki-Hun
    Lee, Young-Joo
    Hoeflich, Klaus P.
    Schmidt-Kittler, Oleg
    Miller, Stephen
    Choi, Eun Kyung
    ONCOTARGET, 2017, 8 (24) : 38592 - 38601
  • [50] Transformation and Stat activation by derivatives of FGFR1, FGFR3, and FGFR4
    Hart, KC
    Robertson, SC
    Kanemitsu, MY
    Meyer, AN
    Tynan, JA
    Donoghue, DJ
    ONCOGENE, 2000, 19 (29) : 3309 - 3320
12345